₹92.30
−1.02%NSE close, 16 Nov 2026
−28.20%
NEPHRO CARE INDIA is a small cap company, listed on NSE SME under the symbol NEPHROCARE. At ₹92.30 a share, the market values the whole company at ₹152 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹89 crore and a net profit of ₹3 crore, an operating margin of 9.4%.
The market values the company at 26.3 times its profit over the last twelve months and 2.49 times its book value; its return on equity is 9.5% and it has almost no borrowings.
Promoters hold 61.71% of the shares. Foreign institutions hold 0.73%, and domestic institutions, mutual funds among them, 0.86%.
Over the past year the share price has fallen 28.2%, and it is 41.0% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | Mar 2024 S | 6M to Mar 2025 S | 6M to Sep 2025 S | Dec 2025 S | 6M to Mar 2026 | Jun 2026 | 6M to Sep 2026 |
|---|---|---|---|---|---|---|---|
The financial results for the period ended September 30, 2026.
The financial results for the period ended September 30, 2026.
| Sales |
|---|
| 14.1 |
| 28.3 |
| 39.3 |
| 22.7 |
| 49.4 |
| 29.2 |
| 62.5 |
| Expenses | 11.3 | 25.5 | 34.9 | 20.7 | 45.5 | 25.6 | 54.0 |
|---|
| Operating profit | 2.8 | 2.8 | 4.4 | 1.9 | 3.9 | 3.6 | 8.5 |
|---|
| Operating margin | 19.9% | 10.0% | 11.2% | 8.5% | 8.0% | 12.4% | 13.5% |
|---|
| Other income | 0.3 | 1.1 | 0.6 | 0.1 | 0.9 | 0.2 | 0.3 |
|---|
| Interest | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 |
|---|
| Depreciation | 0.5 | 2.0 | 2.1 | 1.4 | 3.0 | 1.2 | 2.4 |
|---|
| Profit before tax | 2.5 | 1.8 | 2.8 | 0.6 | 1.9 | 2.6 | 6.2 |
|---|
| Tax | 1.7 | 0.4 | 0.8 | 0.1 | 0.4 | 1.0 | 1.9 |
|---|
| Net profit | 0.8 | 1.5 | 1.9 | 0.4 | 1.4 | 1.6 | 4.4 |
|---|
| EPS (₹) | 0.72 | 0.96 | 1.18 | 0.26 | 0.87 | 0.98 | 2.65 |
|---|
₹ crore, financial years to March.
| Line | FY24 S | FY25 S | FY26 |
|---|---|---|---|
| Sales | 27.2 | 46.0 | 88.7 |
| Expenses | 20.8 | 40.2 | 80.4 |
| Operating profit | 6.5 | 5.9 | 8.3 |
| Operating margin | 23.8% | 12.8% | 9.4% |
| Other income | 0.4 | 1.5 | 1.6 |
| Interest | 0.1 | 0.1 | 0.2 |
| Depreciation | 0.5 | 2.5 | 5.1 |
| Profit before tax | 6.1 | 4.8 | 4.6 |
| Tax | 1.7 | 1.2 | 1.3 |
| Net profit | 4.4 | 3.6 | 3.4 |
| EPS (₹) | 3.80 | 2.38 | 2.04 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY24 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 0.9 | 7.0 | 2.2 | 1.7 |
| From investing | −7.5 | −39.6 | −0.4 | −2.1 |
| From financing | 5.6 | 36.0 | 0.1 | 0.0 |
| Spent on fixed assets | – | −29.2 | −7.7 | −1.5 |
| Free cash flow | – | −22.3 | −5.5 | 0.2 |
Margins, returns, debt, tax and cash.
| Line | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net margin | 16.2% | 7.9% | 3.8% |
| Operating margin | 23.8% | 12.8% | 9.4% |
| Return on equity | 29.3% | 6.8% | 5.9% |
| Return on capital employed | 41.4% | 9.2% | 8.4% |
| Return on assets | 21.0% | 5.3% | 4.6% |
| Debt to equity | 0.00 | 0.00 | 0.00 |
| Interest coverage | 69.10 | 44.90 | 30.00 |
| Debt to assets | 0.00 | 0.00 | 0.00 |
| Current ratio | 0.75 | 2.01 | 2.02 |
| Quick ratio | 0.69 | 1.93 | 1.87 |
| Cash ratio | 0.22 | 0.33 | 0.42 |
| Asset turnover | 1.30 | 0.67 | 1.22 |
| Fixed asset turnover | 4.87 | 1.46 | 2.61 |
| Inventory turnover | – | 10.60 | 11.50 |
| Receivables turnover | 181.50 | 14.30 | 14.70 |
| Gross margin | – | 71.6% | 70.3% |
| Cash from operations to profit | 21.0% | 191.0% | 66.0% |
| Effective tax rate | 28.1% | 24.6% | 27.4% |
SDD Certificate for the quarter ended 30th September 2026
Has informed regarding Submission of the Compliance Report on Corporate Governance for the quarter ended 30th September 2026
A copy Srutinizers report of Annual General Meeting held on September 25, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 25, 2026
The Exchange had sought clarification from Nephro Care India Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the…
The Exchange has sought clarification from Nephro Care India Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the…
Record date for the purpose of Annual General Meeting is 18-Sep-2026.
Intimation regarding Record date, Cut-off date for remote E-Voting & book closure date forthe ensuing 12th Annual General Meeting of the Company
Notice of Annual General Meeting to be held on September 25, 2026
Outcome of Board Meeting held on August 07, 2026.